Ann: Appendix 4C - 2nd quarter and Investor updat, page-8

re: Ann: Appendix 4C - 2nd quarter and Invest... All in all looks good!
However a couple of things concern me,and maybe they shouldnt....

Highlights:
• $5.3 million received from issue of shares and options
• Recruited new management team
• Corporate restructure focusing on US commercialisation
• Preparation for iSonea trading on US OTCQX from 3 January 2012 (Symbol: ISOAY)
• Protocol finalised for US WheezoMeter study to support non-Rx submission to FDA
• Mobile health product development initiated for smartphone asthma management app v1.0
• US asthma consumer quantitative research (n=369) conducted on app usage & monitoring


Bullet point 2 states new management team under THIS quarters highlights(this occured in second quarter)
And $5.3 mill raised but cash at end of quarter is ONLY $3.8
WHAT DID WE DO WITH THE REST????? Its only been 5 weeks????